Skip to main content

Useful Resources for Clinical Research

BayBiotech.NET
Hello All,

Here is a list of some resources related to Clinical Research and Regulatory Affairs, hope you will find them useful for your work! More to follow in my next blog….

Useful Resources

1. Directory of pharmaceutical industry-funded clinical trials, free and easy-to-use interface for patients and health professionals alike to ongoing clinical trials, clinical trial results and complementary information on related issues.
Link: http://www.ifpma.org/clinicaltrials

2. Registry of federally and privately supported clinical trials conducted in the United States and around the world.
Link: http://www.clinicaltrials.gov

3. Opportunities for public involvement in clinical research: People in Research helps members of the public make contact with organizations that want to actively involve them in clinical research.
Link: http://www.peopleinresearch.org

4. Regulatory Affairs Professional Society: society of professionals engaged in regulatory affairs.
Link: http://www.raps.org

5. National Institute of Child Health and Health Development: resource for clinical research related information.
Link: http://www.nichd.nih.gov/health/clinicalresearch/

6. Council For International Organizations Of Medical Sciences
Link: http://www.cioms.ch/index.html

7. FDA Good Clinical Practices: details on regulations around Good Clinical Practices as per FDA guidelines.

Link: http://www.fda.gov/ScienceResearch/SpecialTopics/RunningClinicalTrials/default.htm

8. International Organization of Standardization
Link: http://www.iso.org/iso/home.htm

9. International Conference on Harmonization
Link: http://www.ich.org/cache/compo/276-254-1.html

10. UK Clinical Research Collaboration: a partnership of organizations working to transform the environment for clinical research in the UK.
Link: http://www.ukcrc.org

11. UK Clinical Research Network: The UK Clinical Research Network (UKCRN) supports clinical research and helps to deliver clinical trials and other well designed studies across the UK.
Link: http://www.ukcrn.org.uk

12. Medical Research Council: Medical Research Council (MRC) has been conducting clinical trials to address important public health questions and improve clinical care.
Link: http://www.mrc.ac.uk

Comments

Popular posts from this blog

Group C (Treatment IND) Drugs

BayBiotech.NET Since 1976, National Cancer Institute (NCI) in agreement with FDA has established the Group C classification system to allow access to certain drugs for the cancer patients specifically falling under a category that adequate alternative therapy or if the available alternative therapy has significant toxic effects. Each Group C drug protocol specifies patient eligibility and drug use information. Group C drugs are provided only to properly trained physicians who have registered themselves with NCI using a special form to assure that their patient qualifies under guidelines - or protocols - for the drug. Physicians using drugs under Group C have no reporting requirements to the NCI other than the obligation to report adverse drug reactions. Group C drugs are provided free of charge, and the Centers for Medicare and Medicaid Services provides coverage for care associated with Group C therapy. Making Group C drugs available to the critically ill patients not only provi...

Good Machine Learning Practices

BayBiotech.NET A joint effort by FDA,  United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) and Health Canada have developed guiding principles to help promote utilization of medical devices that are safe and effective and utilize artiificial intelligence and machine learning. To find out more details check out the link here!

Harmonization by Doing (HBD): Japan & U.S. Collaboration

BayBiotech.NET HBD is an international cooperative effort by Japan and US for regulatory convergence for Medical Devices. The efforts are focused on to develop global clinical trials and address regulatory barriers for timely device approvals. To address the needs for additional evaluation, the HBD initiative is a pilot project launched jointly by FDA and MHLW-PMDA for the premarket review of device cardiovascular technology. Instead of taking a theoretical approach to harmonization, HBD is focused on Proof of concept by utilizing parallel development, application submissions and review of actual medical device projects. HBD Study intends to collect and analyze regulatory submission data from multiple applications in the U.S. and Japan. The purpose of the study is to further understand differences that may exist with format and content, to define best practices and to improve globally harmonized processes. To read more about the HBD program, follow the link: http://www.fda.gov/M...